Aquestive Therapeutics AQST
NASDAQ AQST
$3.57 -0.01 (-0.42%)
As of: Nov 12, 2026 · 1:33 PM EST

Aquestive Therapeutics (AQST) Interest & Investment Income (2018 - 2026)

Updated

Aquestive Therapeutics (AQST) posted Interest & Investment Income of $853,000 for Q3 2026, up 178.8% from $306,000 a year earlier but down 3.3% from the prior quarter.

Analysis

Aquestive Therapeutics (AQST) Interest & Investment Income (2018 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Interest & Investment Income at Aquestive Therapeutics was $3.07 million, down 20.2% year-over-year; for FY2025, it was $4.37 million, up 27.1% from FY2024.

  • Annual Interest & Investment Income shows a five-year compound annual growth rate of 101.3% (FY2020 to FY2025).
  • In prior years, Aquestive Therapeutics' Interest & Investment Income was $3.44 million in FY2024 (-78.9%), $16.32 million in FY2023, $99,000 in FY2022 (-76.6%) and $423,000 in FY2021 (+220.5%).
  • Quarterly Interest & Investment Income has run from a low of -$3,000 in Q1 2022 to a high of $14.51 million in Q1 2023 over five years.
  • On a year-over-year basis, Interest & Investment Income increased in five of the last eight quarters, with growth averaging 68.3%.
  • The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q2 2024, with growth of 981.4%; the weakest was Q1 2024, with a decline of 97.7%.
  • According to Business Quant data, Interest & Investment Income for the three prior quarters was $882,000 (Q2 2026), $83,000 (Q1 2026) and $1.25 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 186.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 67.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Aquestive Therapeutics 442.42 Mn 21.68 Mn 3.95 Mn 853,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 853,000.00
Jun 30, 2026 882,000.00
Mar 31, 2026 83,000.00
Dec 31, 2025 1.25 Mn
Sep 30, 2025 306,000.00
Jun 30, 2025 2.10 Mn
Mar 31, 2025 713,000.00
Dec 31, 2024 734,000.00
Sep 30, 2024 979,000.00
Jun 30, 2024 1.40 Mn
Mar 31, 2024 329,000.00
Dec 31, 2023 165,000.00
Sep 30, 2023 1.51 Mn
Jun 30, 2023 129,000.00
Mar 31, 2023 14.51 Mn
Dec 31, 2022 65,000.00
Sep 30, 2022 5,000.00
Jun 30, 2022 32,000.00
Mar 31, 2022 -3,000.00
Dec 31, 2021 135,000.00
API Access

Aquestive Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=AQST&period=max&api_key=YOUR_API_KEY